BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 619346)

  • 21. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE; Høiby N
    Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with ticarcillin and sulfamethoxazole-trimethoprim for infections in patients with cancer.
    Keating MJ; Lawson R; Grose W; Bodey GP
    Arch Intern Med; 1981 Jun; 141(7):926-30. PubMed ID: 7235813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral antibiotics in pediatric patients.
    Malian M; Dajani AS
    Compr Ther; 1983 Dec; 9(12):24-30. PubMed ID: 6368109
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of aztreonam in lower respiratory tract infections.
    Cook JL
    Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic therapy in the management of infections in dental patients.
    Gardner AF
    Ann Dent; 1982; 41(1):7-22. PubMed ID: 6965042
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibiotic treatment of lung disease in cystic fibrosis].
    Biasini GC; Pistocchi E; Miano A
    Pediatr Med Chir; 1983; 5(4):157-60. PubMed ID: 6647075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
    Zabner R; Quinn JP
    Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of bacterial exacerbations of obstructive lung diseases].
    Kozielski J
    Pol Merkur Lekarski; 2011 Oct; 31(184):201-3. PubMed ID: 22097174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New antibacterial agents: the role of new penicillins and cephalosporins in the management of infection in granulocytopenic patients.
    Klastersky J
    Clin Haematol; 1984 Oct; 13(3):587-98. PubMed ID: 6388934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
    Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
    Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infections in immunocompromised patients. II. Established therapy and its limitations.
    Periti P; Mazzei T
    Clin Ther; 1985; 8(1):100-17. PubMed ID: 3854579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
    Wolff LJ
    Am J Pediatr Hematol Oncol; 1984; 6(3):267-76. PubMed ID: 6393790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of resistant bacterial strains during treatment of infections in the respiratory tract.
    Kosmidis J; Koratzanis G
    Scand J Infect Dis Suppl; 1986; 49():135-9. PubMed ID: 3103208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis.
    Rahal JJ; Simberkoff MS
    Ann Intern Med; 1982 Apr; 96(4):468-74. PubMed ID: 7039444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacterial infections and resistance to antibiotics in cystic fibrosis].
    Taccetti G; Repetto T; Procopio E; Marianelli L; Campana S
    Pediatr Med Chir; 1999; 21(5 Suppl):213-8. PubMed ID: 10963010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial therapy in infants and children. Part I. Review of antimicrobial agents.
    Eichenwald HF; McCracken GH
    J Pediatr; 1978 Sep; 93(3):337-56. PubMed ID: 211213
    [No Abstract]   [Full Text] [Related]  

  • 40. Actions and uses of antimicrobial agents in the treatment of musculoskeletal infections.
    Wilkowske CJ; Hermans PE
    Orthop Clin North Am; 1975 Oct; 6(4):1129-44. PubMed ID: 1178163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.